We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.80 | 3.60 | 4.00 | 3.80 | 3.80 | 3.80 | 205,010 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/9/2024 13:22 | https://chatgpt.com/ | wilmer100 | |
02/9/2024 12:18 | NEWCOMERS - RUN! SUCKER STOCK BOILER ROOM IN OPERATION HERE. Rampers here have multiple IDs and will eventually be prosecuted and hopefully jailed. Everything they put here is either a lie, a distortion, one-sided, speculative or irrelevant. Hint: The directors aren't buying. Hint 2: Since its launch in 1994 (THIRTY YEARS AGO!) this PoS share has paid out ZERO in dividends - hahahahaha!!!! :D | neutralpov | |
02/9/2024 11:05 | And if Mr Costa's 'very soon' is 2025+ as his presentation suggests to me then the cumulative will be rosy..as will the Launcher mystery fungicide seed treatment product if it turns out to have an Eden component. | supersonico | |
02/9/2024 10:26 | There's approximately 88 days until year end. One RNS is inevitable , likely 8 in total or so I thought yesterday .That's one every 11 days. But now with the "Greece News" one every 12 to 13 days. 6 of those likely in Q4.6 in 66 gives one in 11 in Q4.So what?Well if it is a pivotal year it's that word-cumulative.If it's scene setting for 2025 as the pivotal year so be it.The bullish case remains Expanding GeographyFurther uses Increased invoicing ?I'm slightly afraid of the half year results as a brake on the wheels on progress. Though the CFO has hinted at EBITDA being close.It's also said repeat orders can be less than the originals.So observing the observation that Greece is relevant to 2024 ( thanks poster for that being underlined ) and last year the board were positive about full year outcome - that's it.Ah after an RNS it's chatter chatter washerwomen mode for about 4 days. See you by the pebbles and the well.Atb | alchemy | |
02/9/2024 10:15 | Another layer of value added to Eden Research Plc, not yet factored into the share price. Each regulatory (new or label extension) approval adds intrinsic value to Eden, even before sales begin. As sales accumulate thereafter, further value will be attributed. Why is there intrinsic value in Eden, purely from regulatory approval? In my opinion, that is because of the 8-10 year cycle for the likes of Syngenta to bring a successfully developed product to market, $300 million and whatever time during that period, a product has been off market and no revenue have been achieved. Even this does not factor in additional cost value for unsuccessful products and time and money spent on this. The ability to view a company like Eden with a significant geographical footprint for multiple products, where substantially less money has been spent and R & D time is in the past makes Eden an attractive investment proposition and an exciting to company to partner with. | investingisatrickygame | |
02/9/2024 08:46 | Desparate time for a guy called Neuts who must think he is superior ... so there's no point even talking with him. | money never sleeps | |
02/9/2024 07:57 | I think we all know that . Order taking is essential. But the big boys we work with aren't doing it for fun and the lurgis we deal with do exist, Take up is keyWith this I agree | alchemy | |
02/9/2024 07:52 | Obtaining Approvals is all very well but unless and until they start selling some product it doesn’t mean very much. | orlando42 | |
02/9/2024 07:36 | Cumulative . That's the word.Cumulative joy that's the phrase | alchemy | |
02/9/2024 06:54 | Wireworm news dropped..plenty more inthecoming. From Eden's Preliminary Results Presention PDF?: "Upcoming news-flow • Mevalone approvals in Central Europe H2, 2024 • Commercial agreements for insecticide H2, 2024 • Emergency Use applications for Cedroz (wireworm) and Ecovelex Q3, 2024 • Commercial agreement(s) for home and garden H2, 2024 • Major label extensions for Mevalone in various countries (e.g. France) Q4, 2024" | supersonico | |
02/9/2024 06:53 | The key part is 2024 growing season: "... a temporary approval in Greece for use on potatoes against wireworms for the 2024 growing season". | money never sleeps | |
02/9/2024 06:27 | Now the question is how much does Eden get per litre. 5000to 6000 hectares in Greece, then the rest of the world. And Wireworms are they nematodes? I think not, so that would be a new application for the same product.Very interesting times ahead. | wilmer100 | |
02/9/2024 06:21 | https://productcatal | wilmer100 | |
02/9/2024 06:05 | Nematicide Approval in Greece Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, is pleased to announce that CedrozÔ has been granted, according to Reg. EU/1107/2009, a temporary approval in Greece for use on potatoes against wireworms for the 2024 growing season. Cedroz, whose distributor in Greece is Eastman Chemical; Eden's commercial partner in a number of countries, will now be permitted for use on potatoes against wireworms. Wireworms are the larvae of click beetles which cause damage to potatoes by forming a mass of holes and mini-tunnels on the vegetables. This pest is becoming increasingly problematic in many crops and regions, and farmers have very few options (most of them based on synthetic insecticides) to minimise its negative impact on the harvest. The Wireworm-infected area of potatoes grown in Greece alone is around 5,000 to 6,000 hectares, meaning that there is a sizeable, commercial opportunity for Cedroz beyond its consolidated uses as a post-planting nematicide in horticultural crops. Sean Smith, Chief Executive Officer of Eden Research, commented: "The granting of this temporary approval indicates that there are no other commercially available, viable alternatives to Cedroz for this particular use. We have seen in previous trials, and even under a previously granted temporary approval in Italy on wireworms, that the product works well and, as such, we are confident that there is a strong business case for this use." | supersonico | |
01/9/2024 20:39 | Above noise all totally irrelevant to the (non-existent) prospects of this SUCKER STOCK (official classification @ stockopedia) This "discussion board" dominated by multi-avatar rampers, one of whom is paid to lie, is a Boiler Room. If one respects the "research" part of this "ThirtyPlus Years Without Dividends" share, buy the stock of the company which will buy it out in the impending prepack Administration.... with $$ only for creditors, NIL for the idiot shareholders. :D | neutralpov | |
01/9/2024 11:09 | BlackRock, State Street and Vanguard are 'arguably the most powerful cartel in human history', Republican candidate Vivek Ramaswamy once said. I read that Vanguard and Blackrock own a lot of each other's shares, and it is difficult to find out who the actual shareholders are. Some of the 'old money' families I'd guess. | weyweyumfozo | |
01/9/2024 07:49 | Just in case your still confused by the Corteva senior management weaponised virtue signaling.. RFK jr spells it out; | supersonico | |
01/9/2024 06:57 | Corteva Chose their Team; Clara Serrano @ClaraSerrano101 · 1 Apr 'Thank you to all my followers for your support on X to date. Going forward, I invite you to follow my LinkedIn account to remain up to date on Corteva’ Southern Europe news. I look forward to connecting with you there!' .................. Igor Teslenko�A @IgorTeslenko4 President, EMEA, at @Corteva 3/4/24 Today concludes my posting on X. Thank you for your support on this platform. I invite you to follow my LinkedIn account to stay informed about all of Corteva's EMEA news. Igor Teslenko🇺 | supersonico | |
01/9/2024 06:52 | Choose your Team; Michael Shellenberger @shellenberger · You may not care about the censorship and banning of X in Brazil. You don't have to. That's because what's happening there isn't really about Brazil. It's about the country being used as a laboratory to roll out totalitarianism worldwide. We ignore it at our peril. | supersonico | |
01/9/2024 06:35 | Direction of Travel news; | supersonico | |
30/8/2024 08:55 | Topping up time, Buys @ 4p soon possible yet again. :D C'mon, as supersonico observed, you can't help yourself, and you're far too fick to seek therapy for your acute condition. :D | neutralpov |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions